Cara Therapeutics | CARA - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Assertio Holdings USD 14.66M 3.81M 2025-09
Cara Therapeutics USD 3.22M 859K 2025-12
Cassava Sciences USD 41.65M 4.44M 2025-12
Chugai Pharma JPY 107.52B 19.72B 2026-03
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
J&J USD 10.46B 1.53B 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Pacira USD 14.01M 1.14M 2026-03
Pfizer USD 4.51B 734M 2026-03
RedHill Biopharma USD 835K 7.03M 2025-06
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12